Insulin‐like growth factor‐I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK‐STAT) pathway
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The insulin‐like growth factor IGF‐I is an important fetal and postnatal growth factor, which is also involved in tissue homeostasis via regulation of proliferation, differentiation, and cell survival. To understand the role of IGF‐I in the pathophysiology of a variety of disorders, including growth disorders, cancer, and neurodegenerative diseases, a detailed knowledge of IGF‐I signal transduction is required. This knowledge may also contribute to the development of new therapies directed at the IGF‐I receptor or other signaling molecules. In this review, we will address IGF‐I receptor signaling through the JAK/STAT pathway in IGF‐I signaling and the role of cytokine‐induced inhibitors of signaling (CIS) and suppressors of cytokine signaling (SOCS). It appears that, in addition to the canonical IGF‐I signaling pathways through extracellular‐regulated kinase (ERK) and phosphatidylinositol‐3 kinase (PI3K)‐Akt, IGF‐I also signals through the JAK/STAT pathway. Activation of this pathway may lead to induction of SOCS molecules, well‐known feedback inhibitors of the JAK/STAT pathway, which also suppress of IGF‐I‐induced JAK/STAT signaling. Furthermore, other IGF‐I‐induced signaling pathways may also be modulated by SOCS. It is conceivable that the effect of these classical inhibitors of cytokine signaling directly affect IGF‐I receptor signaling, because they are able to associate to the intracellular part of the IGF‐I receptor. These observations indicate that CIS and SOCS molecules are key to cross‐talk between IGF‐I receptor signaling and signaling through receptors belonging to the hematopoietic/cytokine receptor superfamily. Theoretically, dysregulation of CIS or SOCS may affect IGF‐I‐mediated effects on body growth, cell differentiation, proliferation, and cell survival. © 2009 International Union of Biochemistry and Molecular Biology, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SOCS proteins, cytokine signalling and immune regulation
Yoshimura, A., Naka, T., & Kubo, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2093 · Cited by 1,580 · cited 1×
“The two principle mechanisms for inhibition of JAK/STAT signaling are binding to the receptor via the SH2 domain, which blocks the recruitment of STAT or other signaling molecules, and attenuating of the catalytic activity of JAK via the SH2 and KIR domains [30].”
BackgroundSOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2
Rui, L., Yuan, M., Frantz, D., Shoelson, S., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200444200 · Cited by 904
Senn, J. J., Klover, P. J., Nowak, I. A., Zimmers, T. A., Koniaris, L. G., Furlanetto, R. W., & Mooney, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210689200 · Cited by 620 · cited 1×
“Inhibition of insulin signaling by SOCS could play a role in insulin resistance in type 2 diabetes [39].”
Background
Cited by
Signalling by insulin and IGF receptors: supporting acts and new players
Siddle, K. (2011) · Journal of Molecular Endocrinology · doi:10.1530/jme-11-0022 · Cited by 456
Lalancette-Hébert, M., Swarup, V., Beaulieu, J. M., Bohacek, I., Abdelhamid, E., Weng, Y. C., Sato, S., & Kriz, J. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1498-12.2012 · Cited by 251
“The functional role of SOCS3 is to act as negative feedback inhibitor of the JAK/STAT pathway by avoiding STAT3 phosphorylation (Krebs and Hilton, 2001; Himpe and Kooijman, 2009).”
BackgroundYang, Y., Li, X., Sun, Q., He, B., Jia, Y., Cai, D., & Zhao, R. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.08.040 · Cited by 36
Metadata
- Authors
- Himpe, E., & Kooijman, R.
- Venue
- BioFactors
- Publisher
- Wiley
- Published
- 2009-01
- Volume
- 35
- Issue
- 1
- Pages
- 76-81
- ISSN
- 0951-6433 (ISSN-L)
- 1872-8081
- OpenAlex
- W1980153644
- Cited by
- 101
- References
- 3
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.